BINDESHWARI SINHA: Open Payments
NPI 1760477277 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 24 payments from 14 companies in 2025. Trend: 2023 $1,271 · 2024 $990 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 4 | $234 |
| Astellas Pharma US Inc | 4 | $100 |
| Edwards Lifesciences Corporation | 3 | $93 |
| Lilly USA, LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Averitas Pharma Inc. | 1 | $32 |
| Dexcom, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Novo Nordisk Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Leqembi, Veozah, SAPIEN 3 Ultra RESILIA, FARXIGA, QUTENZA, Dexcom G6 Transmitter, JARDIANCE, LEQVIO.
Industry payments across FL — which companies pay providers there.
